Navigating Renin-Angiotensin System Inhibitors in Patients with Declines in eGFR.
作者信息
Shulman Rachel, Cohen Jordana B
机构信息
Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
J Am Soc Nephrol. 2024 Oct 1;35(10):1309-1311. doi: 10.1681/ASN.0000000000000470. Epub 2024 Aug 13.
Abstract
摘要
相似文献
1
Navigating Renin-Angiotensin System Inhibitors in Patients with Declines in eGFR.
J Am Soc Nephrol. 2024 Oct 1;35(10):1309-1311. doi: 10.1681/ASN.0000000000000470. Epub 2024 Aug 13.
2
Inhibition of the renin-angiotensin-aldosterone system: how to obtain this.
Curr Pharm Des. 2012;18(7):950-1. doi: 10.2174/138161212799436494.
3
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
4
How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?
Circ Heart Fail. 2014 May;7(3):536. doi: 10.1161/CIRCHEARTFAILURE.113.000843.
5
Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
Life Sci. 2017 Dec 15;191:175-179. doi: 10.1016/j.lfs.2017.10.028.
6
Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
N Engl J Med. 2022 Dec 1;387(22):2021-2032. doi: 10.1056/NEJMoa2210639. Epub 2022 Nov 3.
7
Role of renin-angiotensin system blockade in advanced CKD: to use or not to use?
Hypertens Res. 2022 Jun;45(6):1072-1075. doi: 10.1038/s41440-022-00902-7. Epub 2022 Mar 31.
8
Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes.
J Am Soc Nephrol. 2024 Oct 1;35(10):1402-1411. doi: 10.1681/ASN.0000000000000426. Epub 2024 Jun 18.
9
Angiotensin-converting enzyme inhibitor or Angiotensin receptor blocker use and renal outcomes-reply.
JAMA Intern Med. 2014 Oct;174(10):1706-7. doi: 10.1001/jamainternmed.2014.1578.
10
The authors reply.
Kidney Int. 2014 Oct;86(4):855. doi: 10.1038/ki.2014.172.
引用本文的文献
1
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S239-S251. doi: 10.2337/dc25-S011.
本文引用的文献
1
Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality.
J Am Soc Nephrol. 2024 Oct 1;35(10):1391-1401. doi: 10.1681/ASN.0000000000000425. Epub 2024 Jun 18.
2
Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes.
J Am Soc Nephrol. 2024 Oct 1;35(10):1402-1411. doi: 10.1681/ASN.0000000000000426. Epub 2024 Jun 18.
3
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
4
Association between stopping renin-angiotensin system inhibitors immediately before hemodialysis initiation and subsequent cardiovascular events.
Hypertens Res. 2024 May;47(5):1372-1379. doi: 10.1038/s41440-024-01616-8. Epub 2024 Mar 4.
5
Target Trial Emulation: A Framework for Causal Inference From Observational Data.
JAMA. 2022 Dec 27;328(24):2446-2447. doi: 10.1001/jama.2022.21383.
6
Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
N Engl J Med. 2022 Dec 1;387(22):2021-2032. doi: 10.1056/NEJMoa2210639. Epub 2022 Nov 3.
7
Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study.
Am J Kidney Dis. 2022 Aug;80(2):164-173.e1. doi: 10.1053/j.ajkd.2022.01.002. Epub 2022 Jan 25.
8
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
Kidney Int. 2021 Mar;99(3):559-569. doi: 10.1016/j.kint.2020.10.026.
9
Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.
J Am Soc Nephrol. 2021 Feb;32(2):424-435. doi: 10.1681/ASN.2020050682. Epub 2020 Dec 28.
10
Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study.
BMJ. 2017 Mar 9;356:j791. doi: 10.1136/bmj.j791.
Zotero 插件